tiprankstipranks

Heinz Christoph Maeusli Insider Profile

4 Followers
Heinz Christoph Maeusli, Director at Progenics, holds ― shares in Progenics (Ticker: PGNX), holds 23.34K shares in Lantheus (Ticker: LNTH). Most recently, Heinz Christoph Maeusli ― shares of Progenics on ― for an estimated value of ―.
tipranks
Heinz Christoph Maeusli

Heinz Christoph Maeusli
Progenics (PGNX)
Director

Not Ranked
Heinz Christoph Maeusli has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Heinz Christoph Maeusli's holdings

Insider Roles

Lantheus
(LNTH)
Director
Roles that Heinz Christoph Maeusli holds in companies

Most Profitable Insider Trade

Stock:
Lantheus
(LNTH)
Rating:Informative Sell
Date:May 30, 2024 - Today
Return:-12.40%
The most profitable trade made by Heinz Christoph Maeusli

Heinz Christoph Maeusli's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PGNX
Progenics
Lantheus
May 30, 2024
Director
Uninformative Buy
282.67K
$2.12M
List of latest transactions for each holding click on a transaction to see Heinz Christoph Maeusli's performance on stock

Heinz Christoph Maeusli insider profile FAQ

What is the percentage of profitable transactions made by Heinz Christoph Maeusli?
The percentage of profitable transactions made by Heinz Christoph Maeusli is ―.
    What is the average return per transaction made by Heinz Christoph Maeusli?
    The average return per transaction made by Heinz Christoph Maeusli is ―.
      What stocks does Heinz Christoph Maeusli hold?
      Heinz Christoph Maeusli holds: PGNX, LNTH stocks.
        What was Heinz Christoph Maeusli’s latest transaction?
        Heinz Christoph Maeusli latest transaction was an Uninformative Buy of ―.
          What was Heinz Christoph Maeusli's most profitable transaction?
          Heinz Christoph Maeusli’s most profitable transaction was an Informative Sell of LNTH stock on May 30, 2024. The return on the trade was -12.40%.
            What is Heinz Christoph Maeusli's role in Progenics?
            Heinz Christoph Maeusli's role in Progenics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.